SE8605515D0 - A liquid dosage form for oral administration of a pharmaceutically active substance - Google Patents

A liquid dosage form for oral administration of a pharmaceutically active substance

Info

Publication number
SE8605515D0
SE8605515D0 SE8605515A SE8605515A SE8605515D0 SE 8605515 D0 SE8605515 D0 SE 8605515D0 SE 8605515 A SE8605515 A SE 8605515A SE 8605515 A SE8605515 A SE 8605515A SE 8605515 D0 SE8605515 D0 SE 8605515D0
Authority
SE
Sweden
Prior art keywords
active substance
pharmaceutically active
dosage form
oral administration
liquid dosage
Prior art date
Application number
SE8605515A
Other languages
English (en)
Swedish (sv)
Inventor
K J Mattsson
A G M Nicklasson
R I Sjoqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to SE8605515A priority Critical patent/SE8605515D0/xx
Publication of SE8605515D0 publication Critical patent/SE8605515D0/xx
Priority to NO874960A priority patent/NO177177C/no
Priority to AU81991/87A priority patent/AU609753B2/en
Priority to IE330687A priority patent/IE60149B1/en
Priority to DE8787850382T priority patent/DE3785167T2/de
Priority to EP87850382A priority patent/EP0273890B1/en
Priority to AT87850382T priority patent/ATE87471T1/de
Priority to ES198787850382T priority patent/ES2039480T3/es
Priority to PH8736221A priority patent/PH25287A/en
Priority to DK668787A priority patent/DK668787A/da
Priority to CA000554941A priority patent/CA1317883C/en
Priority to JP62321637A priority patent/JP2778030B2/ja
Priority to FI875645A priority patent/FI94923C/fi
Priority to IL86607A priority patent/IL86607A/xx
Priority to US07/584,385 priority patent/US5085868A/en
Priority to GR930400575T priority patent/GR3007542T3/el
Priority to HK66396A priority patent/HK66396A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8605515A 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance SE8605515D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance
NO874960A NO177177C (no) 1986-12-22 1987-11-27 Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
AU81991/87A AU609753B2 (en) 1986-12-22 1987-12-02 A liquid dosage form for oral administration of a pharmaceutically active substance
IE330687A IE60149B1 (en) 1986-12-22 1987-12-04 A liquid dosage form for oral administration of a pharmaceutically active substance
ES198787850382T ES2039480T3 (es) 1986-12-22 1987-12-07 Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
AT87850382T ATE87471T1 (de) 1986-12-22 1987-12-07 Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
EP87850382A EP0273890B1 (en) 1986-12-22 1987-12-07 A liquid dosage form for oral administration of a pharmaceutically active substance
DE8787850382T DE3785167T2 (de) 1986-12-22 1987-12-07 Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
PH8736221A PH25287A (en) 1986-12-22 1987-12-15 A liquid dosage form or oral administration of a pharmaceutically active substrate
DK668787A DK668787A (da) 1986-12-22 1987-12-18 Flydende doseringsform til oral indgift af farmaceutisk virksomt stof
CA000554941A CA1317883C (en) 1986-12-22 1987-12-21 Liquid dosage form for oral administration of a pharmaceutically active substance
JP62321637A JP2778030B2 (ja) 1986-12-22 1987-12-21 経口投与用液体製剤
FI875645A FI94923C (fi) 1986-12-22 1987-12-21 Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten
IL86607A IL86607A (en) 1986-12-22 1988-06-02 Liquid medicaments for oral administration containing encapsulated drugs in non-aqueous liquid
US07/584,385 US5085868A (en) 1986-12-22 1990-09-17 Liquid dosage form for all oral administration of a pharmaceutically active substance
GR930400575T GR3007542T3 (no) 1986-12-22 1993-04-01
HK66396A HK66396A (en) 1986-12-22 1996-04-18 A liquid dosage form for oral administration of a pharmaceutically active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Publications (1)

Publication Number Publication Date
SE8605515D0 true SE8605515D0 (sv) 1986-12-22

Family

ID=20366721

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Country Status (17)

Country Link
US (1) US5085868A (no)
EP (1) EP0273890B1 (no)
JP (1) JP2778030B2 (no)
AT (1) ATE87471T1 (no)
AU (1) AU609753B2 (no)
CA (1) CA1317883C (no)
DE (1) DE3785167T2 (no)
DK (1) DK668787A (no)
ES (1) ES2039480T3 (no)
FI (1) FI94923C (no)
GR (1) GR3007542T3 (no)
HK (1) HK66396A (no)
IE (1) IE60149B1 (no)
IL (1) IL86607A (no)
NO (1) NO177177C (no)
PH (1) PH25287A (no)
SE (1) SE8605515D0 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
ES2057021T3 (es) * 1988-06-07 1994-10-16 Abbott Lab Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5306507A (en) * 1992-03-26 1994-04-26 Mallinckrodt Specialty Chemicals Company Process and composition containing pamabrom and pyrilamine maleate
US5464625A (en) * 1992-05-08 1995-11-07 Monell Chemical Senses Center Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
US5635200A (en) * 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
WO1994012157A1 (en) * 1992-11-30 1994-06-09 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
ES2601855T3 (es) * 1998-11-25 2017-02-16 Cima Labs Inc. Comprimido de liberación rápida con núcleo recubierto que contiene el fármaco y capa circundante de enmascaramiento del sabor
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
CN1189159C (zh) * 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003084517A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
AU2003249904A1 (en) * 2002-07-02 2004-01-23 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20050037979A1 (en) * 2003-06-05 2005-02-17 Ping Jeffrey H. Tannate compositions and methods of use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
GB201804621D0 (en) * 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation
US20230312842A1 (en) * 2022-02-08 2023-10-05 Fujifilm Business Innovation Corp. Cellulosic particle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
ES416148A1 (es) * 1972-12-26 1976-06-01 Willian H Rorer Inc Un procedimiento para preparar particulas antiacidas mejo- radas.
JPS5420572B2 (no) * 1973-04-27 1979-07-24
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS6136217A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd 経口投与用持効性製剤
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPS6317821A (ja) * 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
NZ221411A (en) * 1986-08-11 1989-10-27 Innovata Biomed Ltd Pharmaceutical compositions containing microcapsules and a surfactant

Also Published As

Publication number Publication date
AU8199187A (en) 1988-06-23
NO874960D0 (no) 1987-11-27
NO874960L (no) 1988-06-23
ATE87471T1 (de) 1993-04-15
HK66396A (en) 1996-04-26
IE60149B1 (en) 1994-06-15
EP0273890A1 (en) 1988-07-06
AU609753B2 (en) 1991-05-09
FI875645A0 (fi) 1987-12-21
NO177177B (no) 1995-04-24
FI875645A (fi) 1988-06-23
JPS63166838A (ja) 1988-07-11
PH25287A (en) 1991-04-30
EP0273890B1 (en) 1993-03-31
FI94923C (fi) 1995-11-27
NO177177C (no) 1995-08-02
DE3785167T2 (de) 1993-07-15
JP2778030B2 (ja) 1998-07-23
GR3007542T3 (no) 1993-08-31
ES2039480T3 (es) 1993-10-01
IE873306L (en) 1988-06-22
IL86607A (en) 1992-03-29
US5085868A (en) 1992-02-04
DE3785167D1 (de) 1993-05-06
DK668787D0 (da) 1987-12-18
CA1317883C (en) 1993-05-18
FI94923B (fi) 1995-08-15
DK668787A (da) 1988-06-23

Similar Documents

Publication Publication Date Title
SE8605515D0 (sv) A liquid dosage form for oral administration of a pharmaceutically active substance
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
DK16487D0 (da) Vacciner til oral indgift
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
IT8667331A0 (it) Dispositivo di erogazione di una sostanza medicinale per l erogazione programmata di una sostanza medicinale utile
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
NZ196288A (en) Pharmaceutical active substance administration
NO892764L (no) Medikamentell administreringsform for droevtyggere.
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
ES2054089T3 (es) Formulaciones orales liquidas.
ES2019634B3 (es) Terapia con clorfeniramina.
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
NO873940D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fosfin-gullforbindelser.
DK286986A (da) Enkeltdosisemballage til injektionsmedicin
ATE21701T1 (de) Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate.
IT8421131A0 (it) Dispositivo e procedimento per somministrare medicinali.